These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 1107123
1. Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insluin secretion. Feldman JM, Chapman B. Diabetologia; 1975 Dec; 11(6):487-94. PubMed ID: 1107123 [Abstract] [Full Text] [Related]
2. Inhibition of pancreatic islet monoamine oxidase by adrenergic antagonists and ethanol. Feldman JM. Endocr Res Commun; 1975 Dec; 2(8):503-20. PubMed ID: 4295 [Abstract] [Full Text] [Related]
6. Effect of increased pancreatic islet norepinephrine, dopamine and serotonin concentration on insulin secretion in the golden hamster. Zern RT, Bird JL, Feldman JM. Diabetologia; 1980 Apr; 18(4):341-6. PubMed ID: 6998806 [Abstract] [Full Text] [Related]
7. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method. Bartonícek V. Med Pharmacol Exp Int J Exp Med; 1967 Apr; 16(2):142-6. PubMed ID: 5298397 [No Abstract] [Full Text] [Related]
8. [The effect of dopamine and MAO inhibitors on centrally stimulated vomiting]. Förster W, Gräbner S. Acta Biol Med Ger; 1966 Apr; 16(6):650-7. PubMed ID: 4383660 [No Abstract] [Full Text] [Related]
9. Effect of L-dopa administration on islet monoamine oxidase activity and glucose-induced insulin release in the mouse. Lundquist I, Panagiotidis G, Stenström A. Pancreas; 1991 Sep; 6(5):522-7. PubMed ID: 1946308 [Abstract] [Full Text] [Related]
10. Effects of two substituted hydrazine monoamine oxidase (MAO) inhibitors on neurotransmitter amines, gamma-aminobutyric acid, and alanine in rat brain. Yamada N, Takahashi S, Todd KG, Baker GB, Paetsch PR. J Pharm Sci; 1993 Sep; 82(9):934-7. PubMed ID: 7901387 [Abstract] [Full Text] [Related]
11. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines. Popov N, Matthies H, Lietz W, Thiemann C, Jassmann E. Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601 [No Abstract] [Full Text] [Related]
12. Inhibition of insulin release by substrates and inhibitors of monoamine oxidase. Aleyassine H, Lee SH. Am J Physiol; 1972 Mar; 222(3):565-9. PubMed ID: 5022664 [No Abstract] [Full Text] [Related]
13. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors. Alemany R, Olmos G, García-Sevilla JA. Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544 [Abstract] [Full Text] [Related]
17. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors. Fagervall I, Ross SB. Biochem Pharmacol; 1986 Apr 15; 35(8):1381-7. PubMed ID: 2870717 [Abstract] [Full Text] [Related]
18. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo. Robinson DS, Lovenberg W, Keiser H, Sjoerdsma A. Biochem Pharmacol; 1968 Jan 15; 17(1):109-19. PubMed ID: 4384242 [No Abstract] [Full Text] [Related]
19. Monoamines in the pancreatic islets of the mouse. 5-hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors. Lundquist I, Ekholm R, Ericson LE. Diabetologia; 1971 Dec 15; 7(6):414-22. PubMed ID: 5004176 [No Abstract] [Full Text] [Related]
20. Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors. Aghajanian GK, Graham AW, Sheard MH. Science; 1970 Sep 11; 169(3950):1100-2. PubMed ID: 5449322 [Abstract] [Full Text] [Related] Page: [Next] [New Search]